BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duan X, Shi Y, Zhang X, Ge X, Fan R, Guo J, Li Y, Li G, Ding Y, Osman RA, Jiang W, Sun J, Luan X, Zhang G. Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody. Biosens Bioelectron 2021;199:113883. [PMID: 34942543 DOI: 10.1016/j.bios.2021.113883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hirabidian M, Bocket L, Demaret J, Vuotto F, Rabat A, Faure K, Labalette M, Hober D, Lefevre G, Alidjinou EK. Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants. J Clin Virol 2022;155:105268. [PMID: 35998394 DOI: 10.1016/j.jcv.2022.105268] [Reference Citation Analysis]
2 Bian L, Li Z, He A, Wu B, Yang H, Wu Y, Hu F, Lin G, Zhang D. Ultrabright nanoparticle-labeled lateral flow immunoassay for detection of anti-SARS-CoV-2 neutralizing antibodies in human serum. Biomaterials 2022;:121694. [PMID: 35977850 DOI: 10.1016/j.biomaterials.2022.121694] [Reference Citation Analysis]
3 Funari R, Fukuyama H, Shen AQ. Nanoplasmonic multiplex biosensing for COVID-19 vaccines. Biosens Bioelectron 2022;208:114193. [PMID: 35421841 DOI: 10.1016/j.bios.2022.114193] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]